Yoshihiro Ohmori

4.7k total citations
124 papers, 4.1k citations indexed

About

Yoshihiro Ohmori is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yoshihiro Ohmori has authored 124 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Immunology, 49 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Yoshihiro Ohmori's work include Immune Response and Inflammation (30 papers), Cytokine Signaling Pathways and Interactions (28 papers) and Renal Transplantation Outcomes and Treatments (23 papers). Yoshihiro Ohmori is often cited by papers focused on Immune Response and Inflammation (30 papers), Cytokine Signaling Pathways and Interactions (28 papers) and Renal Transplantation Outcomes and Treatments (23 papers). Yoshihiro Ohmori collaborates with scholars based in Japan, United States and Slovakia. Yoshihiro Ohmori's co-authors include Thomas A. Hamilton, Robert D. Schreiber, Miki Hiroi, Shigemasa Hanazawa, Shigeru Amano, S Kitano, Julie Tebo, Koichi Hirose, Norio Yoshimura and Kazumasa Mori and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Yoshihiro Ohmori

121 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshihiro Ohmori Japan 35 2.2k 1.4k 1.1k 646 388 124 4.1k
L T May United States 22 2.0k 0.9× 977 0.7× 797 0.7× 352 0.5× 72 0.2× 34 3.8k
Leonie S. Taams United Kingdom 43 4.8k 2.2× 928 0.7× 1.0k 1.0× 316 0.5× 166 0.4× 100 7.0k
Monique M. Helsen Netherlands 30 1.9k 0.8× 977 0.7× 1.6k 1.4× 436 0.7× 96 0.2× 50 4.4k
Lynne Bingle United Kingdom 27 1.5k 0.7× 1.1k 0.8× 1.1k 1.0× 549 0.8× 91 0.2× 59 3.4k
J J Oppenheim United States 34 2.5k 1.1× 919 0.7× 1.2k 1.1× 277 0.4× 70 0.2× 46 4.7k
Shigemasa Hanazawa Japan 32 931 0.4× 416 0.3× 1.3k 1.2× 456 0.7× 854 2.2× 102 3.0k
Steven K. Lundy United States 33 1.8k 0.8× 505 0.4× 786 0.7× 230 0.4× 110 0.3× 59 3.5k
Flavia Bazzoni Italy 36 3.1k 1.4× 871 0.6× 1.7k 1.6× 1.0k 1.6× 55 0.1× 67 5.6k
Shahla Abdollahi‐Roodsaz Netherlands 30 1.9k 0.8× 325 0.2× 1.4k 1.3× 337 0.5× 150 0.4× 50 3.6k
Shigeaki Hida Japan 19 1.7k 0.8× 980 0.7× 1.3k 1.2× 408 0.6× 67 0.2× 48 3.1k

Countries citing papers authored by Yoshihiro Ohmori

Since Specialization
Citations

This map shows the geographic impact of Yoshihiro Ohmori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiro Ohmori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiro Ohmori more than expected).

Fields of papers citing papers by Yoshihiro Ohmori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiro Ohmori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiro Ohmori. The network helps show where Yoshihiro Ohmori may publish in the future.

Co-authorship network of co-authors of Yoshihiro Ohmori

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshihiro Ohmori. A scholar is included among the top collaborators of Yoshihiro Ohmori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshihiro Ohmori. Yoshihiro Ohmori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hiroi, Miki, et al.. (2023). Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line. SHILAP Revista de lepidopterología. 11(2). 31–31. 1 indexed citations
7.
Hiroi, Miki, et al.. (2006). Sulindac, a nonsteroidal anti-inflammatory drug, selectively inhibits interferon-γ-induced expression of the chemokine CXCL9 gene in mouse macrophages. Biochemical and Biophysical Research Communications. 350(2). 339–344. 9 indexed citations
8.
Okamoto, Masahiko, et al.. (2003). Pediatric living-related renal transplantation under tacrolimus as the primary immunosuppressive agent. Transplantation Proceedings. 35(1). 165–166. 1 indexed citations
9.
Matsuyama, Masahide, Masahiko Okamoto, Y Kadotani, et al.. (2002). The role of tissue factor in renal ischemic reperfusion injury by antisense oligodeoxynucleotide. Transplantation Proceedings. 34(5). 1475–1476. 4 indexed citations
10.
Ushigome, Hidetaka, Hajime Sano, Masahiko Okamoto, et al.. (2002). The Role of Tissue Factor in Renal Ischemic Reperfusion Injury of the Rat. Journal of Surgical Research. 102(2). 102–109. 23 indexed citations
11.
Ohmori, Yoshihiro. (2001). [Mechanisms of bone resorption in periodontal disease].. PubMed. 11(3). 302–8. 1 indexed citations
13.
Sonoyama, Teruhisa, et al.. (1995). Clinicopathological Studies of Central Type of Cholangiocarcinoma Compared with Hilar Bile Duct Cancer.. The Japanese Journal of Gastroenterological Surgery. 28(5). 1049–1054. 1 indexed citations
14.
Ohmori, Yoshihiro, et al.. (1994). Interferon-Stimulated Response Element and NFκB Sites Cooperate to Regulate Double-Stranded RNA-Induced Transcription of the IP-10 Gene. Journal of Interferon Research. 14(6). 357–363. 48 indexed citations
15.
Ohmori, Yoshihiro, et al.. (1990). cAMP differentially regulates expression of mRNA encoding IL-1 alpha and IL-1 beta in murine peritoneal macrophages.. The Journal of Immunology. 145(10). 3333–3339. 64 indexed citations
16.
Ohmori, Yoshihiro, Shigemasa Hanazawa, Shigeru Amano, et al.. (1988). Inducing effect of periodontopathic bacteria on interleukin‐1 production by mouse peritoneal macrophages. Oral Microbiology and Immunology. 3(4). 169–172. 18 indexed citations
17.
Hanazawa, Shigemasa, Shigeru Amano, Kimiharu Hirose, et al.. (1988). Inductive effect of recombinant human interleukin‐1 α and β on differentiation of macrophage‐like tumor cell line P388D1. Journal of Cellular Physiology. 136(3). 543–546. 4 indexed citations
18.
Ohmori, Yoshihiro, et al.. (1986). Functional roles of macrophages in periodontal disease. II Macrophages produce a factor stimulating growth and differentiation of an osteoblastic cell line (MC3T3-E1).:Macrophages produce a factor stimulating growth and differentiation of an osteoblastic cell line (MC3T3-E1). Journal of Oral Biosciences. 28(5). 646–653. 1 indexed citations
19.
Hanazawa, Shigemasa, Yoshihiro Ohmori, Shigeru Amano, et al.. (1986). Human purified interleukin‐1 inhibits DNA synthesis and cell growth of osteoblastic cell line (MC3T3‐E1), but enhances alkaline phosphatase activity in the cells. FEBS Letters. 203(2). 279–284. 27 indexed citations
20.
Ohmori, Yoshihiro, et al.. (1985). Functional role of macrophages in periodontal disease: I. Activation of macrophage functions by Bacteroides gingivalis.:I. Activation of macrophage functions by Bacteroides gingivalis. 27(2). 728–732.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026